Informed Consents Clause Samples
The Informed Consents clause requires that parties obtain explicit permission from individuals before collecting, using, or disclosing their personal information or involving them in certain activities. In practice, this means that organizations must provide clear information about the nature, purpose, and potential risks of the activity or data use, and secure a documented agreement from the individual. This clause ensures that individuals are fully aware of and agree to what will happen with their information or participation, thereby protecting their rights and reducing the risk of legal disputes over unauthorized use or lack of transparency.
Informed Consents. Recipient agrees to comply fully with study participants’ informed consent documents as provided by Researcher.
Informed Consents. Immatics shall prepare the patient informed consent form for the Combination Therapy Trial (“ICF”) and provide a draft thereof to Moderna for its review and comment and insertion of information relating to the Moderna Product no later than [**] after approval of the Protocol. Immatics shall implement all comments from Moderna regarding the portion of the ICF relating to the Combination Therapy or any Moderna Product, and any changes to the ICF to the extent relating to the Combination Therapy or any Moderna Product shall be subject to Moderna’s prior written consent. Immatics shall provide the Combination Project Committee with a copy of the final ICF for the Combination Project Committee’s review and approval, which shall be completed within [**] of receipt.
Informed Consents. Strata Oncology shall ensure that each Identified Patient has signed a Patient ICF which: (a) has been approved by the appropriate Institutional Review Board (“IRB”) and complies with all applicable regulatory requirements, including 21 C.F.R Part 56, prior to commencing the Strata Trial; (b) includes the patient’s written authorization to use and disclose health information (including PHI) for research in accordance with HIPAA; (c) includes the patient’s written authorization to the collection and use of the patient’s Tissue Samples as contemplated hereunder; and (d) will include all other consents required for Strata Oncology to provide Clovis with the Tissue Samples and any other information and assistance contemplated in this Agreement. Strata Oncology has provided Clovis with a copy of its current (as of the Effective Date) form of Patient ICF and will submit any proposed modifications to the form Patient ICF to Clovis for its review and comment. Strata Oncology agrees to consider any comments that Clovis provides to Strata Oncology in good faith prior to implementing any changes to the form Patient ICF.